首页> 外文期刊>TMR Integrative Medicine >Meta-analysis for efficacy of modified Zhenwu Decoction combined with western medicine in treatment of heart failure
【24h】

Meta-analysis for efficacy of modified Zhenwu Decoction combined with western medicine in treatment of heart failure

机译:真武汤加西药治疗心力衰竭疗效的Meta分析

获取原文
           

摘要

Abstract Objective: To carry out a systematic evaluation of the efficacy of modified Zhenwu Decoction combined with western medicine in the treatment of heart failure. Methods: Literature was retrieved in China Knowledge Resource Integrated Database (CNKI), Chinese scientific journal database (VIP), Wanfang Data Resource System (WANFANG DATA), PubMed and other traditional Chinese medicine related periodicals by retrieval methods of subject terms combined with free words and computer retrieval combined with manual retrieval. Literature was screened strictly according to the inclusion criteria.The quality of the included literature was evaluated according to the quality standard of Jadad scale and Cochrane collaboration network bias risk assessment tool. The literature data was extracted. RevMan5.3 software was used to analyze data and the curative effect of modified Zhenwu Decoction combined with western medicine was objectively evaluated. Results: The response rate of the experimental group was better than that of the control group [OR = 3.69,95% IC (2.36,5.79)]. The value of EF in the experimental group was higher than that in the control group after treatment [MD = 5.85, 95% IC (3.90, 7.79) ]. The Lee, score of the experimental group was lower than that of the control group after treatment [MD = -1.37, 95% IC (-2.23, -0.52) ]. The value of BNP in the experimental group was less than that in the control group after treatment [MD = -114.48, 95%IC (-186.28, -42.68)]. The life quality score in the experimental group was less than that of the control group after treatment [MD = -8.44, 95%IC (-11.73, -5.15)]. Conclusion: The curative effect of modified Zhenwu Decoction combined with western medicine in the treatment of heart failure is better than the simple western medicine treatment.So modified Zhenwu Decoction combined with western medicine in the treatment of heart failure is worthy of clinical promotion. However, the results of this study still need further validation by more high quality randomized double blind controlled clinical trial because the overall quality of the research included.
机译:摘要目的:对改良的真武汤联合西药治疗心力衰竭的疗效进行系统评价。方法:采用主题词结合自由词的检索方法,在中国知识资源综合数据库(CNKI),中文科学期刊数据库(VIP),万方数据资源系统(WANFANG DATA),PubMed等中药相关期刊中检索文献。和计算机检索与手动检索相结合。严格按照纳入标准筛选文献,根据Jadad量表和Cochrane协作网络偏倚风险评估工具的质量标准对纳入文献的质量进行评估。提取文献数据。采用RevMan5.3软件对数据进行分析,客观评价了改良的真武汤与西药联合治疗的疗效。结果:实验组的反应率优于对照组[OR = 3.69,95%IC(2.36,5.79)]。治疗后,实验组的EF值高于对照组[MD = 5.85,95%IC(3.90,7.79)]。治疗后,实验组的Lee评分低于对照组[MD = -1.37,95%IC(-2.23,-0.52)]。治疗后,实验组的BNP值低于对照组[MD = -114.48,95%IC(-186.28,-42.68)]。治疗后,实验组的生活质量得分低于对照组[MD = -8.44,95%IC(-11.73,-5.15)]。结论:真武汤加西药治疗心力衰竭疗效优于单纯西药治疗,因此,真武汤加西药治疗心力衰竭值得临床推广。但是,由于包括了研究的整体质量,该研究的结果仍需要通过更高质量的随机双盲对照临床试验来进一步验证。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号